Jeerichuda Pattamadilok

Learn More
Our objective was to assess the efficiency of an appointment-letter intervention aimed to increase uptake of cervical cancer screening in women between 35 and 65 years of age. From January, 2007, we(More)
The aim of this study was to evaluate the compliance, response, and side effects of weekly gemcitabine (125 mg/m2) given concomitantly with standard weekly cisplatin (40 mg/m2) and pelvic(More)
The aim of this study was to determine responses, acute adverse effects, and survival outcomes of women with stage IB2 to IVA treated with weekly cisplatin concurrent with pelvic irradiation at(More)
  • 1